European journal of radiology
-
Randomized Controlled Trial Controlled Clinical Trial
CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
Pirfenidone is a new, anti-fibrotic drug used for the treatment of idiopathic pulmonary fibrosis (IPF). The aim of this study was to evaluate the utility of computed tomography (CT) in the imaging assessment of the response to pirfenidone therapy. ⋯ CT can be used to assess pirfenidone-induced slowing of progression of pulmonary fibrosis.